104 related articles for article (PubMed ID: 9434470)
1. [SG-210].
Akira T; Naka H
Nihon Rinsho; 1997 Nov; 55 Suppl():216-20. PubMed ID: 9434470
[No Abstract] [Full Text] [Related]
2. Pharmacological profiles of a novel aldose reductase inhibitor, SPR-210, and its effects on streptozotocin-induced diabetic rats.
Matsui T; Nakamura Y; Ishikawa H; Matsuura A; Kobayashi F
Jpn J Pharmacol; 1994 Feb; 64(2):115-24. PubMed ID: 8028228
[TBL] [Abstract][Full Text] [Related]
3. Effect of SG-210, a novel aldose reductase inhibitor, on impaired polyol pathway in rats received diabetic manipulations.
Horie S; Nagai H; Yuuki T; Narita Y; Tsuda Y; Nakajima T; Nakamura N
J Diabetes Complications; 1998; 12(3):163-9. PubMed ID: 9618072
[TBL] [Abstract][Full Text] [Related]
4. Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites.
El-Kabbani O; Wilson DK; Petrash M; Quiocho FA
Mol Vis; 1998 Sep; 4():19. PubMed ID: 9756955
[TBL] [Abstract][Full Text] [Related]
5. [Fidarestat (SNK-860)].
Hibi C
Nihon Rinsho; 2002 Sep; 60 Suppl 9():594-600. PubMed ID: 12387056
[No Abstract] [Full Text] [Related]
6. Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review.
Schemmel KE; Padiyara RS; D'Souza JJ
J Diabetes Complications; 2010; 24(5):354-60. PubMed ID: 19748287
[TBL] [Abstract][Full Text] [Related]
7. Metabolic alterations of peripheral nerve in diabetes.
Sima AA
Semin Neurol; 1996 Jun; 16(2):129-37. PubMed ID: 8987126
[No Abstract] [Full Text] [Related]
8. Aldose reductase inhibitors and diabetic complications.
Raskin P; Rosenstock J
Am J Med; 1987 Aug; 83(2):298-306. PubMed ID: 3113248
[No Abstract] [Full Text] [Related]
9. Aldose reductase inhibitors: recent developments.
Sarges R; Oates PJ
Prog Drug Res; 1993; 40():99-161. PubMed ID: 8356214
[No Abstract] [Full Text] [Related]
10. Treatment of diabetic neuropathy with inhibitors of the aldose reductase enzyme.
Green AJ; Jaspan JB
J Diabet Complications; 1990; 4(4):138-44. PubMed ID: 2151223
[No Abstract] [Full Text] [Related]
11. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
Hotta N; Sakamoto N
Nihon Rinsho; 1987 Dec; 45(12):3010-27. PubMed ID: 3128677
[No Abstract] [Full Text] [Related]
12. Treatment for diabetic neuropathy.
Watkins PJ
Diabet Med; 1996 Dec; 13(12):1007-8. PubMed ID: 8973880
[No Abstract] [Full Text] [Related]
13. ["Diabetic autonomic neuropathy" series. Epidemiology, pathogenesis, basic therapy and prognosis].
Luft D
MMW Fortschr Med; 2002 May; 144(20):47-50. PubMed ID: 12119885
[No Abstract] [Full Text] [Related]
14. [Correction of diabetic neuropathies using aldose reductase inhibitors and pikamilon].
Kuchmerovskaia TM; Parkhomets PK; Donchenko GV; Obrosova IG; Klimenko AP; Kuchmerovskiĭ NA; Pakirbaeva LV; Efimov AS
Vopr Med Khim; 1998; 44(6):559-64. PubMed ID: 10599142
[TBL] [Abstract][Full Text] [Related]
15. The role of aldose reductase inhibitors in diabetic complications: recent trends.
Kaul CL; Ramarao P
Methods Find Exp Clin Pharmacol; 2001 Oct; 23(8):465-75. PubMed ID: 11838322
[TBL] [Abstract][Full Text] [Related]
16. Neuropathy, retinopathy, and glucose-lowering treatments.
Bloomgarden ZT
Diabetes Care; 2010 Jun; 33(6):e73-8. PubMed ID: 20508223
[No Abstract] [Full Text] [Related]
17. [Diabetic neuropathy].
Yagihashi S
Nihon Rinsho; 2006 Sep; Suppl 3():155-60. PubMed ID: 17022522
[No Abstract] [Full Text] [Related]
18. [Aldose reductase inhibitor SNK-860].
Hibi C
Nihon Rinsho; 1997 Nov; 55 Suppl():212-5. PubMed ID: 9434469
[No Abstract] [Full Text] [Related]
19. Aldose reductase inhibitors and the complications of diabetes mellitus.
Tomlinson DR
Diabet Med; 1993 Apr; 10(3):214-30. PubMed ID: 8485953
[No Abstract] [Full Text] [Related]
20. [Diabetic neuropathy--concept, staging, diagnosis, treatment].
Ida M; Kuroiwa Y
Nihon Rinsho; 2002 Oct; 60 Suppl 10():191-7. PubMed ID: 12430228
[No Abstract] [Full Text] [Related]
[Next] [New Search]
